Advertisement
Review Article| Volume 3, ISSUE 1, P315-335, August 2018

Download started.

Ok

Nonspecific Orbital Inflammation

      Nonspecific orbital inflammation is a diagnosis of exclusion; systemic and pathologic evaluation is required to rule out specific causes of inflammation and other infiltrative diseases.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Advances in Ophthalmology and Optometry
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Kennerdell J.S.
        • Dresner S.C.
        The nonspecific orbital inflammatory syndromes.
        Surv Ophthalmol. 1984; 29: 93-103
        • Lutt J.R.
        • Lim L.L.
        • Phal P.M.
        • et al.
        Orbital inflammatory disease.
        Semin Arthritis Rheum. 2008; 37: 207-222
        • Mombaerts I.
        • Bilyk J.R.
        • Rose G.E.
        • et al.
        Consensus on diagnostic criteria of idiopathic orbital inflammation using a modified Delphi approach.
        JAMA Ophthalmol. 2017; 135: 769
        • Fujii H.
        • Fujisada H.
        • Kondo T.
        • et al.
        Orbital pseudotumor: histopathological classification and treatment.
        Ophthalmologica. 1985; 190: 230-242
        • Bijlsma W.R.
        • Van ’t Hullenaar F.C.
        • Mourits M.P.
        • et al.
        Evaluation of classification systems for nonspecific idiopathic orbital inflammation.
        Orbit. 2012; 31: 238-245
        • Rootman J.
        • Nugent R.
        The classification and management of acute orbital pseudotumors.
        Ophthalmology. 1982; 89: 1040-1048
        • Rosenbaum J.T.
        • Choi D.
        • Harrington C.A.
        • et al.
        Gene expression profiling and heterogeneity of nonspecific orbital inflammation affecting the lacrimal gland.
        JAMA Ophthalmol. 2017; 135: 1156
        • Birch-Hirschfeld A.
        Zur Diagnostik und Pathologie der Orbitaltumoren.
        Ber 32 Versamm Ophthal Ges Heidelberg. 1906; 32: 127-135
        • Grove A.S.
        • Weber A.L.
        Orbital pseudotumor—historical origin and modern relevance.
        Ophthal Plast Reconstr Surg. 2013; 29: 341-346
        • Benedict W.
        • Knight M.
        Inflammatory pseudotumor of the orbit.
        Arch Ophthalmol. 1923; 52: 582-593
        • Rootman J.
        Why “orbital pseudotumour” is no longer a useful concept.
        Br J Ophthalmol. 1998; 82: 339-340
        • Wladis E.J.
        • Iglesias B.V.
        • Gosselin E.J.
        Characterization of the molecular biologic milieu of idiopathic orbital inflammation.
        Ophthal Plast Reconstr Surg. 2011; 27: 251-254
        • Yuen S.J.A.
        Idiopathic orbital inflammation: distribution, clinical features, and treatment outcome.
        Arch Ophthalmol. 2003; 121: 491
        • Shields J.A.
        • Shields C.L.
        • Scartozzi R.
        Survey of 1264 patients with orbital tumors and simulating lesions.
        Ophthalmology. 2004; 111: 997-1008
        • Weber A.L.
        • Romo L.V.
        • Sabates N.R.
        Pseudotumor of the orbit.
        Radiol Clin North Am. 1999; 37: 151-168
        • Berger J.W.
        • Rubin P.A.D.
        • Jakobiec F.A.
        Pediatric orbital pseudotumor: case report and review of the literature.
        Int Ophthalmol Clin. 1996; 36: 161
        • Bloom J.N.
        • Graviss E.R.
        • Byrne B.J.
        Orbital pseudotumor in the differential diagnosis of pediatric uveitis.
        J Pediatr Ophthalmol Strabismus. 1992; 29: 59-63
        • Spindle J.
        • Tang S.X.
        • Davies B.
        • et al.
        Pediatric idiopathic orbital inflammation: clinical features of 30 cases.
        Ophthal Plast Reconstr Surg. 2016; 32: 270-274
        • Nieto J.C.
        • Kim N.
        • Lucarelli M.J.
        Dacryoadenitis and orbital myositis associated with Lyme disease.
        Arch Ophthalmol. 2008; 126: 1165-1166
        • Kawasaki A.
        • Borruat F.-X.
        An unusual presentation of herpes zoster ophthalmicus: orbital myositis preceding vesicular eruption.
        Am J Ophthalmol. 2003; 136: 574-575
        • Alshaikh M.
        • Kakakios A.M.
        • Kemp A.S.
        Orbital myositis following streptococcal pharyngitis.
        J Paediatr Child Health. 2008; 44: 233-234
        • Smith J.W.
        Orbital pseudotumor and Crohn’s disease.
        Am J Gastroenterol. 1992; 87: 405-406
        • Serop S.
        • Vianna R.N.G.
        • Claeys M.
        • et al.
        Orbital myositis secondary to systemic lupus erythematosus.
        Acta Ophthalmol (Copenh). 1994; 72: 520-523
        • Van de Mosselaer G.
        • Van Deuren H.
        • Dewolf-Peeters C.
        • et al.
        Pseudotumor orbitae and myasthenia gravis. A case report.
        Arch Ophthalmol. 1980; 98: 1621-1622
        • Wladis E.J.
        • Iglesias B.V.
        • Adam A.P.
        • et al.
        Toll-like receptors in idiopathic orbital inflammation.
        Ophthal Plast Reconstr Surg. 2012; 28: 273-276
        • Mombaerts I.
        • Goldschmeding R.
        • Schlingemann R.O.
        • et al.
        What is orbital pseudotumor?.
        Surv Ophthalmol. 1996; 41: 66-78
        • Winn B.J.
        • Rootman J.
        Sclerosing orbital inflammation and systemic disease.
        Ophthal Plast Reconstr Surg. 2012; 28: 107-118
        • Lee C.S.
        • Harocopos G.J.
        • Kraus C.L.
        • et al.
        IgG4-associated orbital and ocular inflammation.
        J Ophthalmic Inflamm Infect. 2015; 5: 15
        • Derzko-Dzulynsky L.
        IgG4-related disease in the eye and ocular adnexa.
        Curr Opin Ophthalmol. 2017; 28: 617-622
        • Wallace Z.S.
        • Deshpande V.
        • Stone J.H.
        Ophthalmic manifestations of IgG4-related disease: single-center experience and literature review.
        Semin Arthritis Rheum. 2014; 43: 806-817
        • Oles K.
        • Sładzień J.
        • Bartuś K.
        • et al.
        Characteristics, diagnosis and therapeutic strategies for IgG4-related orbital disease.
        Pharmacol Rep. 2016; 68: 507-513
        • Ding Z.X.
        • Lip G.
        • Chong V.
        Idiopathic orbital pseudotumour.
        Clin Radiol. 2011; 66: 886-892
        • Gordon L.K.
        Orbital inflammatory disease: a diagnostic and therapeutic challenge.
        Eye (Lond). 2006; 20: 1196-1206
        • Gausas R.E.
        • Damani M.R.
        • Cockerham K.P.
        Nonspecific orbital inflammation.
        in: Perry J.D. Singh A.D. Clinical ophthalmic oncology. 2nd edition. Springer, Berlin2014: 45-53
        • Pakdaman M.N.
        Orbital inflammatory disease: pictorial review and differential diagnosis.
        World J Radiol. 2014; 6: 106
        • Uehara F.
        • Ohba N.
        Diagnostic imaging in patients with orbital cellulitis and inflammatory pseudotumor.
        Int Ophthalmol Clin. 2002; 42: 133-142
        • Kapur R.
        • Sepahdari A.R.
        • Mafee M.F.
        • et al.
        MR imaging of orbital inflammatory syndrome, orbital cellulitis, and orbital lymphoid lesions: the role of diffusion-weighted imaging.
        AJNR Am J Neuroradiol. 2008; 30: 64-70
        • Ben Simon G.J.
        • Syed H.M.
        • Douglas R.
        • et al.
        Extraocular muscle enlargement with tendon involvement in thyroid-associated orbitopathy.
        Am J Ophthalmol. 2004; 137: 1145-1147
        • Ebbo M.
        • Daniel L.
        • Pavic M.
        • et al.
        IgG4-related systemic disease: features and treatment response in a French cohort.
        Medicine (Baltimore). 2012; 91: 49-56
        • Carruth B.P.
        • Wladis E.J.
        Inflammatory modulators and biologic agents in the treatment of idiopathic orbital inflammation.
        Curr Opin Ophthalmol. 2012; 23: 420-426
        • Bijlsma W.R.
        • Paridaens D.
        • Kalmann R.
        Treatment of severe idiopathic orbital inflammation with intravenous methylprednisolone.
        Br J Ophthalmol. 2011; 95: 1068-1071
        • Leibovitch I.
        Intraorbital injection of triamcinolone acetonide in patients with idiopathic orbital inflammation.
        Arch Ophthalmol. 2007; 125: 1647
        • Reggie S.
        • Neimkin M.
        • Holds J.
        Intralesional corticosteroid injections as treatment for non-infectious orbital inflammation.
        Orbit. 2018; 37: 41-47
        • Hemady R.
        • Tauber J.
        • Foster C.S.
        Immunosuppressive drugs in immune and inflammatory ocular disease.
        Surv Ophthalmol. 1991; 35: 369-385
        • Smith J.R.
        • Rosenbaum J.T.
        A role for methotrexate in the management of non-infectious orbital inflammatory disease.
        Br J Ophthalmol. 2001; 85: 1220-1224
        • Shah S.S.
        • Lowder C.Y.
        • Schmitt M.A.
        • et al.
        Low-dose methotrexate therapy for ocular inflammatory disease.
        Ophthalmology. 1992; 99: 1419-1423
        • Hatton M.P.
        • Rubin P.A.D.
        • Foster C.S.
        Successful treatment of idiopathic orbital inflammation with mycophenolate mofetil.
        Am J Ophthalmol. 2005; 140: 916-918
        • On A.V.
        • Hirschbein M.J.
        • Williams H.J.
        • et al.
        CyberKnife radiosurgery and rituximab in the successful management of sclerosing idiopathic orbital inflammatory disease.
        Ophthal Plast Reconstr Surg. 2006; 22: 395-397
        • Suhler E.B.
        • Lim L.L.
        • Beardsley R.M.
        • et al.
        Rituximab therapy for refractory orbital inflammation: results of a phase 1/2, dose-ranging, randomized clinical trial.
        JAMA Ophthalmol. 2014; 132: 572
        • Ibrahim I.
        • Barton A.
        • Ibrahim A.
        • et al.
        Idiopathic orbital inflammation successfully treated using rituximab in a patient with rheumatoid arthritis.
        J Rheumatol. 2012; 39: 1485-1486
        • Khosroshahi A.
        • Carruthers M.N.
        • Deshpande V.
        • et al.
        Rituximab for the treatment of IgG4-related disease: lessons from 10 consecutive patients.
        Medicine (Baltimore). 2012; 91: 57-66
        • Savino G.
        • Battendieri R.
        • Siniscalco A.
        • et al.
        Intraorbital injection of Rituximab in idiopathic orbital inflammatory syndrome: case reports.
        Rheumatol Int. 2015; 35: 183-188
        • Jabs D.A.
        Immunosuppression for the uveitides.
        Ophthalmology. 2018; 125: 193-202
        • Garrity J.A.
        • Coleman A.W.
        • Matteson E.L.
        • et al.
        Treatment of recalcitrant idiopathic orbital inflammation (chronic orbital myositis) with infliximab.
        Am J Ophthalmol. 2004; 138: 925-930
        • Wilson M.W.
        • Shergy W.J.
        • Haik B.G.
        Infliximab in the treatment of recalcitrant idiopathic orbital inflammation.
        Ophthal Plast Reconstr Surg. 2004; 20: 381-383
        • Adams A.B.
        • Kazim M.
        • Lehman T.J.
        Treatment of orbital myositis with adalimumab (Humira).
        J Rheumatol. 2005; 32: 1374-1375
        • Hernández-Garfella M.-L.
        • Gracia-García A.
        • Cervera-Taulet E.
        • et al.
        Adalimumab for recurrent orbital myositis in Crohn’s disease: report of a case with a 3-year follow-up.
        J Crohns Colitis. 2011; 5: 265-266
        • Verma S.
        • Kroeker K.I.
        • Fedorak R.N.
        Adalimumab for orbital myositis in a patient with Crohn’s disease who discontinued infliximab: a case report and review of the literature.
        BMC Gastroenterol. 2013; 13: 59
        • Jalaj S.
        • Dunbar K.
        • Campbell A.
        • et al.
        Treatment of pediatric IgG4-related orbital disease with TNF-α inhibitor.
        Ophthal Plast Reconstr Surg. 2018; 34: e10-e12
        • Garcia-Pous M.
        • Hernández-Garfella M.L.
        • Díaz-Llopis M.
        Treatment of chronic orbital myositis with daclizumab.
        Can J Ophthalmol. 2007; 42: 156-157
        • Silpa-archa S.
        • Oray M.
        • Preble J.M.
        • et al.
        Outcome of tocilizumab treatment in refractory ocular inflammatory diseases.
        Acta Ophthalmol (Copenh). 2016; 94: e400-e406
        • Scheinfeld N.
        A comprehensive review and evaluation of the side effects of the tumor necrosis factor alpha blockers etanercept, infliximab and adalimumab.
        J Dermatolog Treat. 2004; 15: 280-294
        • Wegener’s Granulomatosis Etanercept Trial (WGET) Research Group
        Etanercept plus standard therapy for Wegener’s granulomatosis.
        N Engl J Med. 2005; 352: 351-361
        • Taban M.
        • Dupps W.J.
        • Mandell B.
        • et al.
        Etanercept (enbrel)-associated inflammatory eye disease: case report and review of the literature.
        Ocul Immunol Inflamm. 2006; 14: 145-150
        • Lanciano R.
        • Fowble B.
        • Sergott R.C.
        • et al.
        The results of radiotherapy for orbital pseudotumor.
        Int J Radiat Oncol Biol Phys. 1990; 18: 407-411